These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21646076)

  • 1. [Contribution of FDG-PET in the management of pediatric sarcomas in 2011].
    Kolesnikov-Gauthier H; Leblond P; Rocourt N; Carpentier P
    Bull Cancer; 2011 May; 98(5):501-14. PubMed ID: 21646076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of positron emission tomography in the management of patients with sarcoma.
    Benz MR; Tchekmedyian N; Eilber FC; Federman N; Czernin J; Tap WD
    Curr Opin Oncol; 2009 Jul; 21(4):345-51. PubMed ID: 19412096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
    Völker T; Denecke T; Steffen I; Misch D; Schönberger S; Plotkin M; Ruf J; Furth C; Stöver B; Hautzel H; Henze G; Amthauer H
    J Clin Oncol; 2007 Dec; 25(34):5435-41. PubMed ID: 18048826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
    Sheikhbahaei S; Marcus C; Hafezi-Nejad N; Taghipour M; Subramaniam RM
    PET Clin; 2015 Jul; 10(3):375-93. PubMed ID: 26099673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in sarcomas].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S96-102. PubMed ID: 12739341
    [No Abstract]   [Full Text] [Related]  

  • 6. 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.
    Walter F; Federman N; Apichairuk W; Nelson S; Phelps ME; Allen-Auerbach M; Walter MA; Czernin J
    Pediatr Hematol Oncol; 2011 Oct; 28(7):579-87. PubMed ID: 21936620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F-18 FDG-PET for detection of osseous metastatic disease and staging, restaging, and monitoring response to therapy of musculoskeletal tumors.
    Peterson JJ
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):246-60. PubMed ID: 18260035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of repeated F-18 fluorodeoxyglucose imaging in management of patients with bone and soft tissue sarcoma.
    el-Zeftawy H; Heiba SI; Jana S; Rosen G; Salem S; Santiago JF; Abdel-Dayem HM
    Cancer Biother Radiopharm; 2001 Feb; 16(1):37-46. PubMed ID: 11279796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft Tissue Study Group].
    Franzius C; Schulte M; Hillmann A; Winkelmann W; Jürgens H; Bockisch A; Schober O
    Chirurg; 2001 Sep; 72(9):1071-7. PubMed ID: 11594280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F-FDG-PET-CT in soft tissue sarcomas: when to image?].
    Rodríguez-Alfonso B; Mucientes Rasilla J; Mitjavila Casanovas M; Cardona Arboniés J; Cubedo R
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):43-9. PubMed ID: 24094372
    [No Abstract]   [Full Text] [Related]  

  • 12. Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: A systematic review.
    Lim HJ; Johnny Ong CA; Tan JW; Ching Teo MC
    Crit Rev Oncol Hematol; 2019 Nov; 143():1-13. PubMed ID: 31449981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlating metabolic activity on 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients.
    Rakheja R; Makis W; Skamene S; Nahal A; Brimo F; Azoulay L; Assayag J; Turcotte R; Hickeson M
    AJR Am J Roentgenol; 2012 Jun; 198(6):1409-16. PubMed ID: 22623556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is FDG TEP CT practice changing in the management of sarcomas in adults?].
    Kogay M; Thariat J; Benisvy D; Dufour M; Gastaud L; Saada E; Iannessi A; Thyss A
    Bull Cancer; 2016 Sep; 103(9):735-42. PubMed ID: 27452925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can FDG-PET assess the response to chemotherapy and predict tissue necrosis in osteosarcoma and Ewing sarcoma?
    Andreani L; Ipponi E; Ruinato AD; Lupi T; Di Sacco F; Volterrani D; Coccoli L; Capanna R
    Folia Med (Plovdiv); 2024 Apr; 66(2):196-202. PubMed ID: 38690814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma.
    Farina A; Gasperini C; Aparisi Gómez MP; Bazzocchi A; Fanti S; Nanni C
    Semin Nucl Med; 2022 Sep; 52(5):635-646. PubMed ID: 34879906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of fluorine-18 fluorodesoxyglycose-positron emission tomography for treatment monitoring in patients with soft tissue sarcomas.
    Kasper B; Hohenberger P; Strauss LG; Dimitrakopoulou-Strauss A
    Hell J Nucl Med; 2010; 13(1):40-4. PubMed ID: 20411170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging of sarcomas with FDG PET.
    Mendoza H; Nosov A; Pandit-Taskar N
    Skeletal Radiol; 2023 Mar; 52(3):461-475. PubMed ID: 36173459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of chemotherapy response in osteosarcoma with FDG-PET.
    Hamada K; Tomita Y; Inoue A; Fujimoto T; Hashimoto N; Myoui A; Yoshikawa H; Hatazawa J
    Ann Nucl Med; 2009 Jan; 23(1):89-95. PubMed ID: 19205843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis.
    Kubo T; Furuta T; Johan MP; Ochi M
    Eur J Cancer; 2016 May; 58():104-11. PubMed ID: 26990930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.